Related Experiment Video
Updated: Oct 23, 2025

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
Published on: August 19, 2015
Polymeric Composite Matrix with High Biobased Content as Pharmaceutically Relevant Molecular Encapsulation and
Raj Shankar Hazra1,2, Debasmita Dutta3, Babak Mamnoon4
1Department of Mechanical Engineering, North Dakota State University, Fargo, North Dakota 58108, United States.
Researchers developed novel cellulose nanocrystal (CNC)-reinforced poly(l-lactic acid) (PLA) composite beads for controlled drug delivery. These beads effectively release doxorubicin (DOX) in a pH-dependent manner, suppressing triple-negative breast cancer cell growth.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery
Background:
- Controlled drug delivery systems (DDS) are crucial for various clinical applications, including cancer therapy.
- Developing locally implantable DDS with tunable release profiles remains a significant challenge.
Purpose of the Study:
- To design and evaluate cellulose nanocrystal (CNC)-reinforced poly(l-lactic acid) (PLA) composite beads as a locally implantable, controlled-release DDS.
- To assess the performance of these beads using doxorubicin (DOX) for triple-negative breast cancer treatment.
Main Methods:
- Fabrication of CNC-PLA composite beads using a nonsolvent-induced phase separation (NIPS) method.
- Characterization of bead properties, including mechanical stability, porosity, and water uptake.
- In vitro evaluation of DOX release kinetics at different pH values (7.4 and 5.5).
- Assessment of the anti-cancer efficacy of DOX-loaded beads on MBA-MB-231 cells and in human tissue explants.
Main Results:
- CNC loading significantly influenced the mechanical properties, porosity, water uptake, and drug release characteristics of the PLA beads.
- Composite beads exhibited pH-dependent doxorubicin release, with higher release rates at acidic pH (5.5) compared to physiological pH (7.4).
- Drug release followed Korsmeyer's kinetics, indicating diffusion and swelling as primary release mechanisms.
- DOX released from the beads effectively suppressed triple-negative breast cancer cell proliferation and induced apoptosis.
Conclusions:
- CNC-reinforced PLA composite beads represent a promising platform for programmed, locally implantable drug delivery.
- The pH-responsive release profile and demonstrated anti-cancer activity highlight the potential of this biobased DDS for targeted cancer therapy.
- Further development of these biobased platforms could lead to advanced therapeutic strategies with enhanced stability and drug delivery functions.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Biopharmaceutics and Pharmacokinetics: Overview

